Discovery of Pathologic GPCR Aggregation
The family of G-protein-coupled receptors (GPCRs) is one of the most important drug targets. Mechanisms underlying GPCR activation and signaling are therefore of great pharmacologic interest. It was long thought that GPCRs exist and function as monomers. This feature was considered to distinguish GP...
Main Authors: | Ursula Quitterer, Said AbdAlla |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-01-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fmed.2019.00009/full |
Similar Items
-
Pathological AT1R-B2R Protein Aggregation and Preeclampsia
by: Ursula Quitterer, et al.
Published: (2021-10-01) -
The RAF Kinase Inhibitor Protein (RKIP): Good as Tumour Suppressor, Bad for the Heart
by: Joshua Abd Alla, et al.
Published: (2022-02-01) -
Mechanistic insight into the impact of a bivalent ligand on the structure and dynamics of a GPCR oligomer
by: Samman Mansoor, et al.
Published: (2022-01-01) -
The oxytocin receptor represents a key hub in the GPCR heteroreceptor network: potential relevance for brain and behavior
by: Dasiel O. Borroto-Escuela, et al.
Published: (2022-12-01) -
Diversity and bias through receptor-receptor interactions in GPCR heteroreceptor complexes. Focus on examples from dopamine D2 receptor heteromerization
by: Kjell eFuxe, et al.
Published: (2014-05-01)